Testing for antibodies to understand COVID-19 exposure and immunity
SARS-CoV-2 Serological Antibody Testing for Disease Surveillance and Clinical Use
This study is looking for people aged 7 and older from the Kaiser Permanente Northern California health system to help us understand how long antibodies against COVID-19 last and how many people have been exposed to the virus, even if they didn't show any symptoms.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kaiser Foundation Research Institute NIH-funded |
| Lab location | 1 site (Oakland, UNITED STATES) |
| Project ID | NIH-10855011 on NIH RePORTER |
What this research studies
This research focuses on serological testing to detect antibodies against SARS-CoV-2, the virus that causes COVID-19. By identifying individuals who have been exposed to the virus, even if they were asymptomatic, the study aims to provide a clearer picture of the pandemic's epidemiology. Participants, aged 7 and older, will be recruited from the Kaiser Permanente Northern California health system to monitor antibody development over time. The study will also explore the longevity of the antibody response and the risk of seroconversion in different populations.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals aged 7 years and older who are members of the Kaiser Permanente Northern California health system.
Not a fit: Patients who have not been exposed to SARS-CoV-2 or those outside the age range may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of COVID-19 immunity and inform public health strategies.
How similar studies have performed: Previous research has successfully utilized serological testing to assess immunity and exposure in various populations, indicating a promising approach.
Where this research is happening
Oakland, UNITED STATES
- Kaiser Foundation Research Institute — Oakland, United States (Active)
Researchers
- Principal investigator: Skarbinski, Jacek — Kaiser Foundation Research Institute
- Study coordinator: Skarbinski, Jacek
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.